Evidence map›Paper›PMID 39062635›Full record

ArticleGenes2024

Variation of the 3'RR1 HS1.2 Enhancer and Its Genomic Context.

Carla Jodice, Patrizia Malaspina, Bianca Maria Ciminelli, Cristina Martinez-Labarga, Michela Biancolella, Giuseppe Novelli, Andrea Novelletto

Abstract read
In one paragraph

Article in Genes, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Carla JodiceDepartment of Biology, University of Rome Tor Vergata, 00133 Rome, Italy.
Patrizia MalaspinaDepartment of Biology, University of Rome Tor Vergata, 00133 Rome, Italy.ORCID 0000-0002-0067-369X
Bianca Maria CiminelliDepartment of Biology, University of Rome Tor Vergata, 00133 Rome, Italy.
Cristina Martinez-LabargaDepartment of Biology, University of Rome Tor Vergata, 00133 Rome, Italy.
Michela BiancolellaDepartment of Biology, University of Rome Tor Vergata, 00133 Rome, Italy.
Giuseppe NovelliDepartment of Biomedicine and Prevention, University of Rome Tor Vergata, Tor Vergata University Hospital, 00133 Rome, Italy.ORCID 0000-0002-7781-602X
Andrea NovellettoDepartment of Biology, University of Rome Tor Vergata, 00133 Rome, Italy.ORCID 0000-0002-1146-7680

Funding

HORIZON-HLTH-2021-DISEASE-04 program 101057100 (UNDINE)
6 · The paper itself

Abstract

In humans, the HS1.2 enhancer in the Ig heavy-chain locus is modular, with length polymorphism. Previous studies have shown the following features for this variation: (i) strong population structuring; (ii) association with autoimmune diseases; and (iii) association with developmental changes in Ig expression. The HS1.2 region could then be considered as a contributor to inter-individual diversity in humoral response in adaptive immunity. We experimentally determined the HS1.2-length class genotype in 72 of the 1000 Genomes CEU cell lines and assigned the HS1.2 alleles to haplotypes defined by 18 landmark SNPs. We also sequenced the variable portion and ~200 bp of the flanking DNA of 34 HS1.2 alleles. Furthermore, we computationally explored the ability of different allelic arrangements to bind transcription factors. Non-random association between HS1.2 and Gm allotypes in the European population clearly emerged. We show a wealth of variation in the modular composition of HS1.2, with five SNPs further contributing to diversity. Longer alleles offer more potential sites for binding but, for same-length alleles, SNP variation creates/destroys potential binding sites. Altogether, the arrangements of modules and SNP alleles both inside and outside HS1.2 denote an organization of diversity far from randomness. In the context of the strong divergence of human populations for this genomic region and the reported disease associations, our results suggest that selective forces shaped the pattern of its diversity.

Indexed as

Enhancer Elements, GeneticPolymorphism, Single NucleotideAllelesBinding SitesGenome, HumanHaplotypesHumansTranscription FactorsTranscription FactorsHS1.2 Ig enhancerIg allotypesimmunoglobulinstranscription factor binding

Identifiers

PMID39062635
PMCPMC11275349

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.